Stock Price Quote

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1734.852.8 (+0.16 %)
PREV CLOSE ( ) 1732.05
OPEN PRICE ( ) 1737.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1522
TODAY'S LOW / HIGH ( )1710.30 1748.00
52 WK LOW / HIGH ( )1303 2029
NSE1735.200.8 (+0.05 %)
PREV CLOSE( ) 1734.40
OPEN PRICE ( ) 1733.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1735.20 (105)
VOLUME 80114
TODAY'S LOW / HIGH( ) 1708.20 1751.90
52 WK LOW / HIGH ( )1385.75 2030
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-12 1976
Management Info
Arun Duggal - Chairman - Managing Director
Registered Office

Address Neelam Centre, ' B 'wing,4th Floor, Hind Cycle Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022- 2482 2222

Email secretarialijftjbpharma.com

Website www.jbpharma.com

Registrars Details
Datamatics Business Solutions Ltd.
Plot No. A 16 & 17,Part B Cross Lane,MIDC, Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

15May JB Chemicals & Pharmaceuticals informs
JB Chemicals & Pharmaceuticals has informed that it enclosed newspap..
23Apr JB Chemicals & Pharmaceuticals informs
JB Chemicals & Pharmaceuticals has informed that the Company has sch..
21Apr J.B. Chemicals & Pharmaceuticals secur
J.B. Chemicals & Pharmaceuticals has received approval from United S..
21Apr J.B. Chemicals & Pharmaceuticals rises
J.B. Chemicals & Pharmaceuticals is currently trading at Rs. 1664.50..
18Mar J.B. Chemicals & Pharmaceuticals infor
J.B. Chemicals & Pharmaceuticals has informed that the Compensation..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit14986525.4
Gross Profit 1991.7 8771.1
Operating Profit 2445.110526.8
Net Sales 9013.437229.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  5907.60 (1.17%)
M.Cap ( in Cr)9806.25
Glaxosmithkline Phar (BSE)
peergroup  3366.50 (2.04%)
M.Cap ( in Cr)57030.54
SMS Lifesciences (BSE)
peergroup  1180.45 (1.33%)
M.Cap ( in Cr)356.88
Jenburkt Pharma (BSE)
peergroup  1334.35 (1.14%)
M.Cap ( in Cr)588.89
Laurus Labs (BSE)
peergroup  679.90 (1.94%)
M.Cap ( in Cr)36690.50

Shareholding Pattern

PROMOTERS 47.84%
MUTUAL FUNDS/UTI 16.26%
NON-INSTITUTION 15.14%
FI/BANKS/INSURANCE 1.77%
FII 0.01%
GOVERNMENT 0%

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.